However, in these women, the lowest effective dose shouldbe used for the shortest possible duration, each decision to start HRT shouldbe made on an individual basis with a fully informed woman and treatment shouldbe re-evaluated at least annually in light of new knowledge and any changes inthe woman’s risk factors.The CSM has further advisedthat HRT should no longer be considered as the first choice treatment for theprevention of osteoporosis in women who are at increased risk of fractures, asthe risks are considered to outweigh the benefits. However, HRT may...